Growth factor delivery-based tissue engineering: general approaches and a review of recent developments

The identification and production of recombinant morphogens and growth factors that play key roles in tissue regeneration have generated much enthusiasm and numerous clinical trials, but the results of many of these trials have been largely disappointing. Interestingly, the trials that have shown benefit all contain a common denominator, the presence of a material carrier, suggesting strongly that spatio-temporal control over the location and bioactivity of factors after introduction into the body is crucial to achieve tangible therapeutic effect. Sophisticated materials systems that regulate the biological presentation of growth factors represent an attractive new generation of therapeutic agents for the treatment of a wide variety of diseases. This review provides an overview of growth factor delivery in tissue engineering. Certain fundamental issues and design strategies relevant to the material carriers that are being actively pursued to address specific technical objectives are discussed. Recent progress highlights the importance of materials science and engineering in growth factor delivery approaches to regenerative medicine.

[1]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[2]  Tao L Lowe,et al.  Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. , 2008, Biomaterials.

[3]  W. Sebald,et al.  Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.

[4]  Charles Tator,et al.  Novel intrathecal delivery system for treatment of spinal cord injury , 2003, Experimental Neurology.

[5]  M. Fussenegger,et al.  Drug-sensing hydrogels for the inducible release of biopharmaceuticals. , 2008, Nature materials.

[6]  J. Isner,et al.  Therapeutic Angiogenesis for Coronary Artery Disease , 2002, Annals of Internal Medicine.

[7]  J L West,et al.  Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. , 2001, Biomaterials.

[8]  Charles Tator,et al.  A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. , 2009, Tissue engineering. Part A.

[9]  David J Mooney,et al.  Regulating myoblast phenotype through controlled gel stiffness and degradation. , 2007, Tissue engineering.

[10]  Rui L Reis,et al.  Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. , 2009, Biomacromolecules.

[11]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[12]  B. Amsden,et al.  Combined and sequential delivery of bioactive VEGF165 and HGF from poly(trimethylene carbonate) based photo-cross-linked elastomers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Masashi Komeda,et al.  Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. , 2005, Journal of vascular surgery.

[14]  Toshiyuki Kanamori,et al.  Reversible and Efficient Proton Dissociation of Spirobenzopyran-Functionalized Poly(N-isopropylacrylamide) in Aqueous Solution Triggered by Light Irradiation and Temporary Temperature Rise , 2004 .

[15]  P. Ascenzi,et al.  Preparation and characterization of pH- and temperature-sensitive pullulan microspheres for controlled release of drugs. , 2008, Biomaterials.

[16]  Tomoyuki Ishikawa,et al.  Rapid and reversible shape changes of molecular crystals on photoirradiation , 2007, Nature.

[17]  J. Hubbell,et al.  Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[19]  You Han Bae,et al.  Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.

[20]  Yoshihiro Ito,et al.  Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.

[21]  David J. Mooney,et al.  Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.

[22]  Y. Ikada,et al.  Surfactant-Free Preparation of Biodegradable Hydrogel Microspheres for Protein Release , 1999 .

[23]  Kristi S Anseth,et al.  Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. , 2009, Biomaterials.

[24]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[25]  L. Schmidt‐Mende,et al.  ZnO - nanostructures, defects, and devices , 2007 .

[26]  Charles H Tator,et al.  Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. , 2006, Biomaterials.

[27]  Peter X Ma,et al.  Surface modification of interconnected porous scaffolds. , 2005, Journal of biomedical materials research. Part A.

[28]  Rui L. Reis,et al.  Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. , 2009, Biomaterials.

[29]  Soong Ho Um,et al.  Enzyme-catalysed assembly of DNA hydrogel , 2006, Nature materials.

[30]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[31]  L. Orci,et al.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.

[32]  P. M. Welch A tunable dendritic molecular actuator. , 2005, Nano letters.

[33]  J. Ware,et al.  Therapeutic angiogenesis in cardiovascular disease , 2003, Nature Reviews Drug Discovery.

[34]  A. Domb,et al.  Chemical Interactions Between Drugs Containing Reactive Amines with Hydrolyzable Insoluble Biopolymers in Aqueous Solutions , 1994, Pharmaceutical Research.

[35]  S. Ashley,et al.  The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. , 2008, Biomaterials.

[36]  F. Siccardi Considerations concerning the host-parasite relationship of Escherichia coli in poultry. , 1975, American journal of veterinary research.

[37]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. , 2004, Microvascular research.

[38]  M. Shoichet,et al.  Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. , 2004, Journal of biomedical materials research. Part A.

[39]  V. Hasırcı,et al.  Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.

[40]  F. Krause,et al.  Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. , 2008, The Journal of bone and joint surgery. American volume.

[41]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[42]  Ralph Müller,et al.  Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. , 2006, Biomacromolecules.

[43]  Philip R. Kuhl,et al.  Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.

[44]  Michiya Matsusaki,et al.  Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering. , 2005, Biomacromolecules.

[45]  Brian H Annex,et al.  A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans , 2002, Clinical pharmacology and therapeutics.

[46]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Robert E Guldberg,et al.  Sustained release of BMP-2 in a lipid-based microtube vehicle. , 2009, Acta biomaterialia.

[48]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[49]  Antonios G. Mikos,et al.  Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications , 2005 .

[50]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[51]  Koichi Masuda,et al.  Chapter 62: TISSUE ENGINEERING FOR REGENERATION AND REPLACEMENT OF THE INTERVERTEBRAL DISC , 2006 .

[52]  Antonios G Mikos,et al.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.

[53]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[54]  Doo Sung Lee,et al.  Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid--liquid phase separation of a PLLA--dioxane--water system. , 2002, Journal of biomedical materials research.

[55]  Sung Wan Kim,et al.  Sulfonamide-based pH- and temperature-sensitive biodegradable block copolymer hydrogels. , 2006, Biomacromolecules.

[56]  J. Hubbell,et al.  Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. , 2005, Biophysical journal.

[57]  G. Tucker Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.

[58]  K. Anseth,et al.  Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Yong Wang,et al.  Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release. , 2010, Chemical communications.

[60]  D. Wise,et al.  Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. , 1997, Journal of biomedical materials research.

[61]  Takashi Miyata,et al.  A reversibly antigen-responsive hydrogel , 1999, Nature.

[62]  D. Mooney,et al.  Regulating activation of transplanted cells controls tissue regeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[64]  Giovanna Pitarresi,et al.  Biodegradable and pH-sensitive hydrogels for potential colon-specific drug delivery: characterization and in vitro release studies. , 2008, Biomacromolecules.

[65]  Krishnendu Roy,et al.  Biomaterials for stem cell differentiation. , 2008, Advanced drug delivery reviews.

[66]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[67]  S. Guelcher,et al.  The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. , 2009, Biomaterials.

[68]  VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.

[69]  J. Hubbell,et al.  Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. , 2005, Acta biomaterialia.

[70]  Eben Alsberg,et al.  Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue Engineering , 2001, Biotechnology progress.

[71]  J. Hubbell,et al.  Bioactive biomaterials. , 1999, Current opinion in biotechnology.

[72]  Mark C Manning,et al.  The stability factor: importance in formulation development. , 2002, Current pharmaceutical biotechnology.

[73]  J. Isner,et al.  Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. , 1994, Circulation.

[74]  J. Hubbell,et al.  Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[75]  Shigeru Deguchi,et al.  Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles , 1993 .

[76]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[77]  H. Chung,et al.  Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor. , 2007, Journal of biomedical materials research. Part A.

[78]  J. Fisher,et al.  Thermoreversible hydrogel scaffolds for articular cartilage engineering. , 2004, Journal of biomedical materials research. Part A.

[79]  Daniel G. Anderson,et al.  Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D J Mooney,et al.  Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[81]  Y. Uchida,et al.  Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.

[82]  G. McConnell,et al.  Enzyme responsive polymer hydrogel beads. , 2005, Chemical communications.

[83]  Robert Langer,et al.  Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. , 2006, Biomaterials.

[84]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[85]  M. Fehlings,et al.  The Safety and Efficacy of OP-1 (rhBMP-7) as a Replacement for Iliac Crest Autograft in Posterolateral Lumbar Arthrodesis: A Long-term (>4 Years) Pivotal Study , 2008, Spine.

[86]  N. Cameron,et al.  Emulsion-Derived Foams (PolyHIPEs) Containing Poly(ε-caprolactone) as Matrixes for Tissue Engineering , 2001 .

[87]  P. Kligfield,et al.  Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. , 1999, Annals of surgery.

[88]  David J. Mooney,et al.  Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.

[89]  Fa-Ming Chen,et al.  In vitro cellular responses to scaffolds containing two microencapulated growth factors. , 2009, Biomaterials.

[90]  Dean-Mo Liu,et al.  Magnetic-sensitive silica nanospheres for controlled drug release. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[91]  Jae Sun Yoo,et al.  Novel injectable pH and temperature sensitive block copolymer hydrogel. , 2005, Biomacromolecules.

[92]  Mizuo Maeda,et al.  DNA-responsive hydrogels that can shrink or swell. , 2005, Biomacromolecules.

[93]  K. Akiyoshi,et al.  Thermoresponsive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: heat shock protein-like activity of artificial molecular chaperone. , 2005, Biomacromolecules.

[94]  N. Cameron,et al.  Emulsion-derived foams (PolyHIPEs) containing poly(epsilon-caprolactone) as matrixes for tissue engineering. , 2001, Biomacromolecules.

[95]  J. Hubbell,et al.  Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. , 2007, The Journal of thoracic and cardiovascular surgery.

[96]  Kristi S. Anseth,et al.  Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties , 2009, Science.

[97]  David J Mooney,et al.  Protein-based signaling systems in tissue engineering. , 2003, Current opinion in biotechnology.

[98]  Chi‐Hwa Wang,et al.  In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. , 2009, Journal of biomedical materials research. Part A.

[99]  A. Maruyama,et al.  Thermosensitive transparent semi-interpenetrating polymer networks for wound dressing and cell adhesion control. , 2008, Biomacromolecules.

[100]  Daniel Scherman,et al.  Growth factor delivery approaches in hydrogels. , 2009, Biomacromolecules.

[101]  Robert Langer,et al.  Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.

[102]  Charles Tator,et al.  Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord , 2005, Experimental Neurology.

[103]  T. Sheffield,et al.  Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. , 2004, Biomacromolecules.

[104]  R. K. Evans,et al.  Analysis of plasmid DNA from a pharmaceutical perspective. , 1998, Journal of pharmaceutical sciences.

[105]  David J Mooney,et al.  Integrated approach to designing growth factor delivery systems , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[106]  Antonios G Mikos,et al.  Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[107]  J. Hubbell,et al.  Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.

[108]  Antonios G Mikos,et al.  Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. , 2005, Biomaterials.

[109]  E. Smela,et al.  Microfabricating conjugated polymer actuators. , 2000, Science.

[110]  Jennifer L. West,et al.  Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .

[111]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[112]  Jörg A Auer,et al.  Localized insulin-like growth factor I delivery to enhance new bone formation. , 2003, Bone.

[113]  Michael Cross,et al.  Growth factors in development, transformation, and tumorigenesis , 1991, Cell.

[114]  D. Puleo,et al.  In vitro effects of combined and sequential delivery of two bone growth factors. , 2004, Biomaterials.

[115]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[116]  R Langer,et al.  Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.

[117]  David J. Mooney,et al.  Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.

[118]  K. Leong,et al.  Fabrication of controlled release biodegradable foams by phase separation. , 1995, Tissue engineering.

[119]  Taizo Shiraishi,et al.  Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel , 2008, Cancer science.

[120]  Micheline Piquette-Miller,et al.  Biocompatibility of injectable chitosan-phospholipid implant systems. , 2009, Biomaterials.

[121]  Vasif Hasirci,et al.  Sequential growth factor delivery from complexed microspheres for bone tissue engineering. , 2008, Biomaterials.

[122]  Brian H Annex,et al.  The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003 .

[123]  Franz E Weber,et al.  Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.

[124]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[125]  Yuquan Wei,et al.  Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity , 2009, Growth factors.

[126]  Eben Alsberg,et al.  Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.

[127]  S. Mirza,et al.  Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. , 2006, The Journal of bone and joint surgery. American volume.

[128]  Siccardi Fj Considerations concerning the host-parasite relationship of Escherichia coli in poultry. , 1975 .

[129]  M. Madou,et al.  Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics , 2005, Nature Materials.

[130]  J M Powers,et al.  Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. , 1995, Journal of biomaterials science. Polymer edition.

[131]  F. Isik,et al.  Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells , 2001, Molecular and Cellular Biochemistry.

[132]  S. Bhatia,et al.  Protease-triggered unveiling of bioactive nanoparticles. , 2008, Small.

[133]  Gordon L. Amidon,et al.  The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.

[134]  J. Isner,et al.  Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. , 1994, The American journal of physiology.

[135]  D. S. Lee,et al.  Functionalized injectable hydrogels for controlled insulin delivery. , 2008, Biomaterials.

[136]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[137]  David J Mooney,et al.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.

[138]  E. Kang,et al.  Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering. , 2009, Tissue engineering. Part A.

[139]  Jordi Casanovas,et al.  Conducting polymer actuator mechanism based on the conformational flexibility of calix[4]arene. , 2006, Angewandte Chemie.

[140]  David J Mooney,et al.  Spatiotemporal control over growth factor signaling for therapeutic neovascularization. , 2007, Advanced drug delivery reviews.

[141]  Parkson Lee-Gau Chong,et al.  Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[142]  B. V. von Specht,et al.  Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.

[143]  Antonios G Mikos,et al.  In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[144]  David J. Mooney,et al.  Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.

[145]  W. Sebald,et al.  Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. , 1999, Journal of molecular biology.

[146]  Kevin E. Healy,et al.  A novel method to fabricate bioabsorbable scaffolds , 1995 .

[147]  Matthias P Lutolf,et al.  Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. , 2007, Biomaterials.

[148]  J. Hubbell,et al.  Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[149]  Dustin J. Maxwell,et al.  Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. , 2007, Journal of biomedical materials research. Part A.

[150]  Smadar Cohen,et al.  The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.

[151]  Martin Ehrbar,et al.  Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[152]  David Putnam,et al.  Polymers for gene delivery across length scales , 2006, Nature materials.

[153]  Vesselin Shanov,et al.  A multi-wall carbon nanotube tower electrochemical actuator. , 2006, Nano letters.

[154]  Kristi S Anseth,et al.  Controlling Affinity Binding with Peptide‐Functionalized Poly(ethylene glycol) Hydrogels , 2009, Advanced functional materials.

[155]  A. Sieron,et al.  Site-specific interaction of bone morphogenetic protein 2 with procollagen II. , 2002, Cytokine.

[156]  R. Zhuo,et al.  Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release. , 2008, Biomacromolecules.

[157]  J. Vacanti,et al.  Transplantation of hepatocytes using porous, biodegradable sponges. , 1994, Transplantation proceedings.

[158]  Antonios G Mikos,et al.  Thermoresponsive hydrogels in biomedical applications. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[159]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[160]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[161]  Lorenz Meinel,et al.  Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. , 2009, Biomaterials.

[162]  A. Metters,et al.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[163]  R. Langer,et al.  Light-induced shape-memory polymers , 2005, Nature.

[164]  Smadar Cohen,et al.  The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. , 2009, Biomaterials.

[165]  J. Schalkwijk,et al.  Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. , 2007, Biomaterials.

[166]  J. Pearlman,et al.  Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. , 1999, Circulation.

[167]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[168]  J. Benoit,et al.  Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. , 2003, Biomaterials.

[169]  T. Albert,et al.  The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. , 2008, The spine journal : official journal of the North American Spine Society.

[170]  H. Ohgushi,et al.  Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells. , 2002, Journal of biomedical materials research.

[171]  David A. Cheresh,et al.  Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis , 2003, The Journal of cell biology.

[172]  D. Mooney,et al.  Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. , 2009, Biomaterials.

[173]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[174]  J. Ware,et al.  Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. , 2002, The Journal of thoracic and cardiovascular surgery.

[175]  S J Bryant,et al.  The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels. , 2001, Biomaterials.

[176]  Antonios G Mikos,et al.  Biomimetic materials for tissue engineering. , 2003, Biomaterials.

[177]  R. Langer,et al.  Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. , 1994, Biomaterials.

[178]  D. Mooney,et al.  Hydrogels for tissue engineering. , 2001, Chemical Reviews.

[179]  A. Asthagiri,et al.  Tunable interplay between epidermal growth factor and cell–cell contact governs the spatial dynamics of epithelial growth , 2009, Proceedings of the National Academy of Sciences.

[180]  D. Mooney,et al.  Polymers for pro- and anti-angiogenic therapy. , 2007, Biomaterials.

[181]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[182]  M. Noda,et al.  Nanogel‐based delivery system enhances PGE2 effects on bone formation , 2007, Journal of cellular biochemistry.

[183]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[184]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[185]  Y. Iwasaki,et al.  Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: interaction with proteins and chaperone-like activity. , 2005, Biomacromolecules.

[186]  Martin Ehrbar,et al.  Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[187]  L. Meinel,et al.  Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[188]  Anna Gutowska,et al.  Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. , 2002, Biomacromolecules.

[189]  Jeffrey A. Hubbell,et al.  Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth , 2004, Circulation research.

[190]  D. Rifkin,et al.  Cell signaling events: a view from the matrix. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[191]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[192]  A. Mikos,et al.  Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers. , 2008, Biomacromolecules.

[193]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[194]  R. Eavey,et al.  Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold , 2000, The Laryngoscope.

[195]  Jiehyun Seong,et al.  New thermogelling poly(organophosphazenes) with methoxypoly(ethylene glycol) and oligopeptide as side groups , 2005 .

[196]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[197]  Jean M. J. Fréchet,et al.  A macromolecular delivery vehicle for protein-based vaccines: Acid-degradable protein-loaded microgels , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[198]  Eun-Suk Kim,et al.  Material-based deployment enhances efficacy of endothelial progenitor cells , 2008, Proceedings of the National Academy of Sciences.

[199]  David J Mooney,et al.  Synthetic extracellular matrices for tissue engineering and regeneration. , 2004, Current topics in developmental biology.

[200]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 , 2004 .

[201]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[202]  N. Ortéga,et al.  Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[203]  Richard T. Lee,et al.  Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.